Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: For many years TPL's chart showed that the 148 was due to expire in 2011
3
Jul 02, 2012 03:14PM

148 is an improvement patent on 789 not an uriginal patent filing.

Share
New Message
Please login to post a reply